Log In|Sign Up
ENMyoclonic Epilepsy of Lafora (EPM2)
Alias:
Lafora Disease
Epm2
Epilepsy, Progressive Myoclonic 2b
Epilepsy, Progressive Myoclonic 2a
Progressive Myoclonic Epilepsy Type 2
Progressive Myoclonus Epilepsy Type 2
Epilepsy, Progressive Myoclonic, 2b
Lafora's Disease
Pme Type 2
Epm2a
Melf
Progressive Myoclonic Epilepsy Lafora Type
Lafora Progressive Myoclonic Epilepsy
Epilepsy, Progressive Myoclonic, 2a
Epilepsy, Progressive Myoclonic 2
Progressive Myoclonic Epilepsy 2a
Progressive Myoclonic Epilepsy 2b
Progressive Myoclonic Epilepsy 2
Epilepsy, Myoclonic, of Lafora
Lafora Body Disease
Epm2b
Lbd
Ld
Favorite
Myoclonic Epilepsy of Lafora, also known as lafora disease, is related to progressive myoclonus epilepsy 10 and myoclonic epilepsy of unverricht and lundborg, and has symptoms including myoclonus, hallucinations, visual and unspecified visual loss. An important gene associated with Myoclonic Epilepsy of Lafora is EPM2A (EPM2A Glucan Phosphatase, Laforin), and among its related pathways/superpathways are Metabolism and Glycosaminoglycan metabolism. The drugs Insulin and Insulin, Globin Zinc have been mentioned in the context of this disorder. Affiliated tissues include liver and brain, and related phenotypes are lafora bodies and seizure
Related ID：
Basic Information
Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
Medical Symptom
#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
Gene & Mutation
#
Gene
Function
Score
Mutations
Related Drugs
Name
CAS Number
Status
Phase
Disease Model
Category
Name
MGI
Related Gene
Strain of Origin
Publications
References Literature
Title
PMID
Journal
Year
IF
